1. Home
  2. EXAS vs CW Comparison

EXAS vs CW Comparison

Compare EXAS & CW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$103.38

Market Cap

19.6B

Sector

Health Care

ML Signal

HOLD

Logo Curtiss-Wright Corporation

CW

Curtiss-Wright Corporation

HOLD

Current Price

$690.84

Market Cap

21.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXAS
CW
Founded
1995
1929
Country
Employees
N/A
N/A
Industry
Medical Specialities
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
19.6B
21.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EXAS
CW
Price
$103.38
$690.84
Analyst Decision
Buy
Buy
Analyst Count
19
6
Target Price
$84.27
$603.00
AVG Volume (30 Days)
2.4M
257.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
0.14%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$19.40
$9.59
Revenue Next Year
$13.54
$8.19
P/E Ratio
N/A
$53.90
Revenue Growth
N/A
N/A
52 Week Low
$38.81
$266.88
52 Week High
$103.54
$709.99

Technical Indicators

Market Signals
Indicator
EXAS
CW
Relative Strength Index (RSI) 69.20 64.56
Support Level $103.14 $633.25
Resistance Level $103.87 $709.99
Average True Range (ATR) 0.35 29.15
MACD -0.12 1.35
Stochastic Oscillator 72.08 81.42

Price Performance

Historical Comparison
EXAS
CW

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About CW Curtiss-Wright Corporation

Curtiss-Wright Corporation delivers engineered products and services to commercial, defence, power generation, and other industrial markets. It offers industrial vehicle components, control systems, weapons handling systems, pumps, valves, and other solutions. The company has three reportable segments based on the markets serviced: Naval & Power, which provides coolant pumps, power-dense compact motors, generators, secondary propulsion systems, pumps, pump seals, valves, control rod drive mechanisms, and fastening systems that also generate maximum revenue for the company; Its others segments are Aerospace & Industrial and Defense Electronics. Geographically, the company generates its key revenue from the United States of America, followed by the United Kingdom and other countries.

Share on Social Networks: